Skip to main content
Veterinary Medicines

Milbemycin oxime Praziquantel Chew Alfamed 12.5 mg / 125.0 mg chewable tablets for dogs

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
Milbemycin oxime Praziquantel Chew Alfamed 12.5 mg / 125.0 mg chewable tablets for dogs
Milbemycin oxime/Praziquantel Alfamed 12,5 mg/125 mg comprimidos revestidos por película para cães
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    12.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    125.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • 1 box with 1 blister, each blister contains 2 chewable tablets
  • 1 box with 2 blisters, each blister contains 2 chewable tablets
  • 1 box with 12 blisters, each blister contains 2 chewable tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfamed
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 1647/02/24DFVPT
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0413/002
Concerned member states:
  • Belgium
  • France
  • Germany
  • Ireland
  • Italy
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 14/10/2025